Table 2.

Clinical data of patients with AVR accompanied by circulating AECA or nota

ParameterAECA(+)(n = 13)AECA(−)(n = 26)P
Age (yr)41.9 ± 7.638.5 ± 6.60.161
Gender (male/female)8/515/111.000
Previous renal transplantation (%)2 (15.4)0 (0.0)0.105
Pretransplantation CDC positive (%)00
PRA positive (n [%])
    before transplantation2 (15.4)4 (15.4)1.000
    on rejection2/12 (16.7)7 (26.9)0.689
Baseline immunosuppressants (n [%])
    MMF+CsA+Pred5 (38.5)10 (38.5)1.000
    MMF+TAC+Pred6 (46.2)14 (53.8)0.741
    Aza+CsA+Pred2 (15.4)2 (7.7)0.589
    IL-2mAb induction5 (38.5)10 (28.5)1.000
  • a AVR, acute vascular rejection; Aza, azathioprine; CDC, complement-dependent cytotoxicity cross-match; CsA, cyclosporine; MMF, mycophenolate mofetil; Pred, prednisone; TAC, tacrolimus.